Showing results (91-100 of 458) with videos related to
Sort By:
Pageof 46
Pharmacogenomics|November 22, 2005
Concordance of pharmacogenetic markers in germline and colorectal tumor DNASharon Marsh, Mary Ann Mallon, Paul Goodfellow, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecanGuang Xu, Wanghai Zhang, Margaret K Ma, et al.American Journal of Clinical Pathology|June 1, 2005
Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasmsWanghai Zhang, John Hart, Howard L McLeod, et al.Pharmacogenomics|July 15, 2005
The pharmacogenetics of coumarin therapyDeepak Voora, Howard L McLeod, Charles Eby, et al.Journal of Human Genetics|August 24, 2004
Distribution of ITPA P32T alleles in multiple world populationsSharon Marsh, Cristi R King, Ranjeet Ahluwalia, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines?Jane L Yen-Revollo, Richard M Goldberg, Howard L McLeodTranslational Lung Cancer Research|February 9, 2026
Utility of various programmed death-ligand 1 (PD-L1) assays in predicting the clinical benefit of immune checkpoint inhibitors in PD-L1-expressing non-small-cell lung cancer patients: a systematic reviewRoss A Soo, Darren Wan-Teck Lim, James Chih-Hsin Yang, et al.Advances in Experimental Medicine and Biology|June 1, 2017
Personalized Treatment Through Detection and Monitoring of Genetic Aberrations in Single Circulating Tumor CellsSwee Jin Tan, Trifanny Yeo, Sarvesh Abhay Sukhatme, et al.Pharmacogenomics|February 23, 2005
CEPH individuals are representative of the European American population: implications for pharmacogeneticsMelissa A Meucci, Sharon Marsh, James W Watters, et al.FEBS Letters|July 1, 2004
Novel human CYP2A6 alleles confound gene deletion analysisMiki Nakajima, Ryoko Yoshida, Tatsuki Fukami, et al.Pageof 46